Figure 2From: Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesKaplan–Meier curves. a. Primary efficacy outcome, b. Principal safety outcome and c. Major bleeding. VKA, Vitamin K antagonist.Back to article page